Hyphens Pharma (1J5): Undervalued Proxy to ASEAN Pharmaceuticals | Current: S$0.20 | Target: S$0.29 | Upside: +45% |

Hi everybody, My staff comprising of Bryan, Jin Koi and I are collaborating within the Investor-One Stock Pitch Challenge 2019 underneath th

3 Exciting Small Cap Stocks With Promising Growth
Non trend transitions to trend. Has the EURUSD non-trended long enough?
Market Watch 2019 – SG Banks

Hi everybody,

My staff comprising of Bryan, Jin Koi and I are collaborating within the Investor-One Stock Pitch Challenge 2019 underneath the staff identify Prinsep Capital. Out of the 220 SGX-Catalist shares,  we had to decide a inventory to provoke a Buy name on. After conducting numerous screenings and understanding the story of assorted Catalist counters, Hyphens Pharma stood out to us as one of the crucial high-quality undervalued and undercovered inventory which we imagine has vital upside potential. Please do give it a learn as now we have work on it tirelessly over the previous two months.

You can obtain our analysis report right here: Hyphens Pharma Prinsep Capital

Do present us your assist by voting for us, Prinsep Capital. The high six groups with the very best variety of votes will make it into the finals the place we’d be pitching the corporate in entrance of a judging panel. We hope you

COMMENTS

We use cookies to give you the best online experience. By agreeing you accept the use of cookies in accordance with our cookie policy.